Literature DB >> 16757604

Molecular mimicry revisited: gut bacteria and multiple sclerosis.

Fred C Westall1.   

Abstract

Molecular mimicry is a possible explanation for autoimmune side effects of microorganism infections. Protein sequences from a particular microorganism are compared to known autoimmune immunogens. For diseases such as multiple sclerosis (MS), where the infectious agent is unknown, guesses to its identity are made. Mimics are assumed to be rare. This study takes a radically different approach. Reported sequences from all known human bacterial and viral agents were searched for autoimmune immunogen mimics. Three encephalitogenic peptides, whose autoimmune requirements have been studied extensively, were selected for comparison. Mimics were seen in a wide variety of organisms. For each immunogen, the mimics were found predominantly in nonpathogenic gut bacteria. Since the three immunogens used in this study are related to MS, it is suggested that a microorganism responsible for autoimmune activity in MS could be a normally occurring gut bacterium. This would explain many of the peculiar MS epidemiological data and why no infective agent has been identified for MS and supports recently found MS gut metabolism abnormalities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757604      PMCID: PMC1489420          DOI: 10.1128/JCM.02532-05

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  47 in total

1.  Cause and prevention of postinfectious and postvaccinal neuropathies in light of a new theory of autoimmunity.

Authors:  F C Westall; R Root-Bernstein
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

2.  Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis.

Authors:  U Jahnke; E H Fischer; E C Alvord
Journal:  Science       Date:  1985-07-19       Impact factor: 47.728

3.  Effect of substitution of D-alanine for L-alanine on activity and conformation of an encephalitogenic peptide.

Authors:  G Khanarian; S A Margetson; W J Moore; S J Pasaribu; F C Westall
Journal:  Biochem Biophys Res Commun       Date:  1979-03-15       Impact factor: 3.575

4.  An explanation of prevention and suppression of experimental allergic encephalomyelitis.

Authors:  F C Westall; R S Root-Bernstein
Journal:  Mol Immunol       Date:  1983-02       Impact factor: 4.407

5.  Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice.

Authors:  S Amor; D Baker; N Groome; J L Turk
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

6.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity.

Authors:  R S Fujinami; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

7.  Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice.

Authors:  J M Greer; V K Kuchroo; R A Sobel; M B Lees
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

8.  Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes.

Authors:  M D Mannie; P Y Paterson; D C U'Prichard; G Flouret
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Serotonin binding sites. I. Structures of sites on myelin basic protein, LHRH, MSH, ACTH, interferon, serum albumin, ovalbumin and red pigment concentrating hormone.

Authors:  R S Root-Bernstein; F C Westall
Journal:  Brain Res Bull       Date:  1984-04       Impact factor: 4.077

10.  Rapid elimination of a synthetic adjuvant peptide from the circulation after systemic administration and absence of detectable natural muramyl peptides in normal serum at current analytical limits.

Authors:  A Fox; K Fox
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more
  22 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.

Authors:  Leslie E Summers deLuca; Natalia B Pikor; Jennifer O'Leary; Georgina Galicia-Rosas; Lesley A Ward; Dustin Defreitas; Trisha M Finlay; Shalina S Ousman; Lucy R Osborne; Jennifer L Gommerman
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

Review 3.  Microbiota—implications for immunity and transplantation.

Authors:  Jonathan S Bromberg; W Florian Fricke; C Colin Brinkman; Thomas Simon; Emmanuel F Mongodin
Journal:  Nat Rev Nephrol       Date:  2015-05-12       Impact factor: 28.314

Review 4.  The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.

Authors:  Samantha N Freedman; Shailesh K Shahi; Ashutosh K Mangalam
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

5.  Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.

Authors:  K M De Felice; M Novotna; F T Enders; W A Faubion; W J Tremaine; O H Kantarci; L E Raffals
Journal:  Aliment Pharmacol Ther       Date:  2014-10-27       Impact factor: 8.171

6.  Role of molecular mimicry and polyclonal cell activation in the induction of pathogenic β2-glycoprotein I-directed immune response in Balb/c mice upon hyperimmunization with tetanus toxoid.

Authors:  Marijana Stojanović; Vladimir Petrušić; Irena Zivković; Aleksandra Inić-Kanada; Ivana Stojićević; Emilija Marinković; Ljiljana Dimitrijević
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

7.  Cross-reactivity of Antibodies Directed to the Gram-Negative Bacterium Neisseria gonorrhoeae With Heat Shock Protein 60 and ATP-Binding Protein Correlates to Reduced Mitochondrial Activity in HIBCPP Choroid Plexus Papilloma Cells.

Authors:  B Reuss; H Schroten; H Ishikawa; A R Asif
Journal:  J Mol Neurosci       Date:  2015-06-17       Impact factor: 3.444

8.  Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.

Authors:  D Pisa; R Alonso; F J Jiménez-Jiménez; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-16       Impact factor: 3.267

9.  A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?

Authors:  Kerrie Vaughan; Bjoern Peters; Kevin C O'Connor; Roland Martin; Alessandro Sette
Journal:  J Neuroimmunol       Date:  2013-12-12       Impact factor: 3.478

Review 10.  The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Authors:  Carlos R Camara-Lemarroy; Luanne Metz; Jonathan B Meddings; Keith A Sharkey; V Wee Yong
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.